MacroGenics
Stock Forecast, Prediction & Price Target
MacroGenics Financial Estimates
MacroGenics Revenue Estimates
MacroGenics EBITDA Estimates
MacroGenics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $75.64M N/A | $151.94M 100.86% | $58.74M -61.33% | Avg: $102.53M Low: $56.55M High: $134.05M avg. 74.53% | Avg: $109.82M Low: $64.18M High: $154.54M avg. 7.11% | Avg: $111.89M Low: $65.38M High: $157.45M avg. 1.88% | Avg: $205.05M Low: $119.82M High: $288.54M avg. 83.26% |
Net Income
% change YoY
| $-190.85M N/A | $-120.02M 37.11% | $-9.05M 92.45% | Avg: $-137.29M Low: $-238.42M High: $-20.43M avg. -1415.70% | Avg: $-187.84M Low: $-278.68M High: $-4.33M avg. -36.82% | Avg: $-157.91M Low: $-241.50M High: $-72.59M avg. 15.93% | Avg: $-117.04M Low: $-178.99M High: $-53.80M avg. 25.88% |
EBITDA
% change YoY
| $-202.79M N/A | $-121.41M 40.12% | $2.01M 101.66% | Avg: $-98.41M Low: $-128.67M High: $-54.28M avg. -4979.28% | Avg: $-105.41M Low: $-148.33M High: $-61.60M avg. -7.11% | Avg: $-107.39M Low: $-151.12M High: $-62.76M avg. -1.88% | Avg: $-196.81M Low: $-276.95M High: $-115.01M avg. -83.26% |
EPS
% change YoY
| -$3.18 N/A | -$1.95 38.67% | -$0.15 92.30% | Avg: -$1.99 Low: -$3.85 High: -$0.33 avg. -1226.36% | Avg: -$2.05 Low: -$4.5 High: -$0.07 avg. -3.13% | Avg: -$2.55 Low: -$3.9 High: -$1.17 avg. -24.27% | Avg: -$1.89 Low: -$2.89 High: -$0.87 avg. 25.88% |
Operating Expenses
% change YoY
| $275.78M N/A | $265.97M -3.55% | $217.21M -18.33% | Avg: $67.45M Low: $37.20M High: $88.19M avg. -68.94% | Avg: $72.24M Low: $42.22M High: $101.66M avg. 7.11% | Avg: $73.60M Low: $43.01M High: $103.57M avg. 1.88% | Avg: $134.89M Low: $78.82M High: $189.81M avg. 83.26% |
FAQ
What is MacroGenics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -352.67% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -238.42M, average is -137.29M and high is -20.43M.
What is MacroGenics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 41.69% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $56.55M, average is $102.53M and high is $134.05M.
What is MacroGenics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -306.97% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.85, average is -$1.99 and high is $-0.33.
What is the best performing analyst?
In the last twelve months analysts have been covering MacroGenics stock. The most successful analyst is Kaveri Pohlman whose win rate is 50%. He has correctly predicted 1/2 price targets.